Literature DB >> 4435033

The effect of reserpine treatment on the chronotropic and inotropic sensitivities of the perfused guinea-pig heart to norepinephrine and calcium.

D A Taylor, D P Westfall, W W Fleming.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4435033     DOI： 10.1016/0014-2999(74)90176-9

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  6 in total

1.  Proceedings: Reserpine-induced supersensitivity to the rate and tension responses to isoprenaline and salbutamol of guinea-pig atria.

Authors:  K J Broadley; P Lumley
Journal:  Br J Pharmacol       Date:  1975-10       Impact factor: 8.739

2.  The individual and combined effects of hypothermia and reserpine pretreatment on the rate and tension responses to isoprenaline and salbutamol in guinea-pig atria [proceedings].

Authors:  K J Broadley; C Duncan
Journal:  Br J Pharmacol       Date:  1976-07       Impact factor: 8.739

3.  The effect of pretreatment with reserpine on the diastolic potential of guinea-pig atrial cells.

Authors:  D A Taylor; D P Westfall; S De Moraes; W W Fleming
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  beta-Adrenoceptor ligand binding and supersensitivity to isoprenaline of ventricular muscle after chronic reserpine pretreatment.

Authors:  M H Hawthorn; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-09       Impact factor: 3.000

5.  Selective reserpine-induced supersensitivity of the positive inotropic and chronotropic responses to isoprenaline and salbutamol in guinea-pig isolated atria.

Authors:  K J Broadley; P Lumley
Journal:  Br J Pharmacol       Date:  1977-01       Impact factor: 8.739

6.  The influence of temperature upon reserpine-induced supersensitivity of guinea-pig isolated atria to isoprenaline and salbutamol.

Authors:  C Duncan; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-03       Impact factor: 3.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.